NCT04973345View on ClinicalTrials.gov

Terbutaline Sulfate in Adults With Asthma

PHASE2/PHASE3SuspendedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

July 7, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Asthma

Interventions

DRUG

Terbutaline

management of asthma symptoms

Trial Locations (2)

80045

University of Colorado, Aurora

05401

University of Vermont, Burlington

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Duke Health

OTHER

collaborator

The Emmes Company, LLC

INDUSTRY

lead

Kanecia Obie Zimmerman

OTHER

NCT04973345 - Terbutaline Sulfate in Adults With Asthma | Biotech Hunter | Biotech Hunter